Vision Care Consumer Health News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vision care consumer health. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vision Care Consumer Health Today - Breaking & Trending Today

Bausch + Lomb Co. (NYSE:BLCO) Receives $19.13 Average PT from Analysts

Shares of Bausch + Lomb Co. (NYSE:BLCO – Get Rating) have been assigned a consensus rating of “Hold” from the eight research firms that are covering the firm, MarketBeat.com reports. Five equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 […] ....

National Bank , Tower Research Capital , Vision Care Consumer Health , Ophthalmic Pharmaceuticals , Lomb Co , Royal Bank , Morgan Stanley , Needham Company , Lomb Corporation , Barclays Plc , Get Rating , Lomb Stock , Consumer Health Care , Lomb Daily ,

Bausch + Lomb (NYSE:BLCO) Reaches New 52-Week High at $19.97

Bausch + Lomb Co. (NYSE:BLCO – Get Rating)’s stock price reached a new 52-week high during mid-day trading on Friday . The company traded as high as $19.97 and last traded at $19.80, with a volume of 11980 shares traded. The stock had previously closed at $19.67. Analyst Ratings Changes BLCO has been the topic […] ....

Lomb Co , Norges Bank , Nomura Holdings Inc , Vision Care Consumer Health , Needham Company , Ophthalmic Pharmaceuticals , Lomb Corporation , Jpmorgan Chase Co , Deutsche Bank Aktiengesellschaft , Get Rating , Bank Aktiengesellschaft , Lomb Stock , Funds Weigh In On Bausch , Pension Plan Investment Board , Mangrove Partners , Consumer Health Care , Lomb Daily ,

Bausch + Lomb Co. (NYSE:BLCO) Stake Lessened by Alamar Capital Management LLC

Alamar Capital Management LLC lessened its holdings in Bausch + Lomb Co. (NYSE:BLCO – Get Rating) by 5.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 101,795 shares of the company’s stock after selling 6,090 shares during the […] ....

Alamar Capital Management , Quinn Opportunity Partners , Exchange Commission , Vision Care Consumer Health , Wolverine Asset Management , Lomb Co , Lomb Corporation , Jpmorgan Chase Co , Morgan Stanley , Ophthalmic Pharmaceuticals , Clark Estates Inc , Royal Bank , Gabelli Funds , Get Rating , Capital Management , Opportunity Partners , Asset Management , Consumer Health Care , Lomb Daily , Bausch Lomb , Nyse Blco , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Bausch + Lomb Co. (NYSE:BLCO) Receives $20.33 Consensus Target Price from Analysts

Shares of Bausch + Lomb Co. (NYSE:BLCO – Get Rating) have received an average recommendation of “Moderate Buy” from the fourteen research firms that are currently covering the firm, Marketbeat Ratings reports. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average […] ....

Morgan Stanley , Royal Bank , Deutsche Bank Aktiengesellschaft , Lomb Corporation , Lomb Co , Ophthalmic Pharmaceuticals , Tower Research Capital , Vision Care Consumer Health , National Bank , Needham Company , Barclays Plc , Get Rating , Marketbeat Ratings , Bank Aktiengesellschaft , Consumer Health Care , Lomb Daily , Bausch Lomb , Nyse Blco ,

Bausch + Lomb (NYSE:BLCO) Given New $22.00 Price Target at HC Wainwright

Bausch + Lomb (NYSE:BLCO – Get Rating) had its target price increased by HC Wainwright from $19.00 to $22.00 in a report published on Friday morning, The Fly reports. BLCO has been the topic of a number of other research reports. JPMorgan Chase & Co. lifted their price objective on Bausch + Lomb from $15.00 […] ....

Lomb Corporation , Deutsche Bank Aktiengesellschaft , Morgan Stanley , Asset Management , Ophthalmic Pharmaceuticals , Norges Bank , Nomura Holdings Inc , Vision Care Consumer Health , Needham Company , Maple Rock Capital Partners Inc , Jpmorgan Chase Co , Get Rating , Bank Aktiengesellschaft , Moderate Buy , Lomb Stock , Investors Weigh In On Bausch , Rock Capital Partners , Road Asset Management , Nomura Holdings , Consumer Health Care , Lomb Daily , Bausch Lomb , Nyse Blco , Boost Price Target , Hc Wainwright ,